A Comprehensive Look at New OIG Guidance In Medicare

https://youtu.be/0O8WhCj3dDA?si=MSFR1M0cUjzE-i8r

Understanding Where the Medicare Advantage Guidance Fits

The new OIG Guidance In Medicare Advantage gives healthcare organizations a more focused framework for understanding and managing compliance risks within the Medicare Advantage sector.

The Medicare Advantage Industry Segment-Specific Compliance Program Guidance, or ICPG, does not replace the OIG’s General Compliance Program Guidance or the seven elements of an effective compliance program; instead, it adds Medicare Advantage-specific considerations to that foundation.

That distinction matters when you are responsible for compliance, operations, quality, or leadership within a healthcare organization. Your existing compliance program should already address policies and procedures, training, auditing, monitoring, reporting, and other core elements, but the Medicare Advantage ICPG gives you an opportunity to examine how those components address the particular risks associated with Medicare Advantage.

Why Medicare Advantage Has Received Specific Attention

Medicare Advantage has grown significantly, with more than half of Medicare enrollees using Medicare Advantage programs in 2025 and current estimates placing enrollment at approximately 35.5 million people. That scale, combined with concerns involving prior authorization, quality of care, utilization management, and other areas, helps explain why the OIG has identified Medicare Advantage as an area requiring focused compliance attention.

For healthcare leaders, the growth of Medicare Advantage also means the related compliance risks can reach deeply into everyday operations. A provider organization may not operate a Medicare Advantage plan, for example, but if it treats Medicare Advantage beneficiaries, works with a Medicare Advantage organization, or participates as a vendor or downstream entity, the guidance may still have implications for its compliance program.

Identify the Medicare Advantage Risks Within Your Organization

One of the most useful aspects of the OIG Guidance In Medicare Advantage is its focus on specific areas of risk. Rather than treating compliance as a broad concept, organizations can use the guidance to examine the processes that create exposure within their particular operations.

The guidance identifies areas including:

• Risk adjustment and data integrity, including diagnosis coding, documentation, health risk assessments, and potential overpayments

• Utilization management, medical necessity, and prior authorization

• Marketing, enrollment, steering, and potential inducements

• Network adequacy and the accuracy of provider directories

• Claims and payment integrity

• Quality of care and ownership structures that could create compliance concerns

The important question for your organization is not simply whether one of these risks exists on paper. You need to determine how the risk appears within your actual processes, who owns that process, what controls exist, how those controls are monitored, and what happens when your organization identifies a problem.

Artificial Intelligence Requires Active Oversight

Artificial intelligence creates another area where healthcare organizations need to understand how compliance intersects with operations. New technologies are entering the healthcare market rapidly, including tools that connect with electronic medical records and assist providers with clinical decision-making.

Before allowing an AI vendor to connect with your systems, your organization should understand what the technology does, what information it accesses, how it influences decisions, and what oversight remains with your healthcare professionals. The same consideration applies to Medicare Advantage organizations using algorithms in utilization management or claims decisions, where the technology should not replace the clinical judgment and patient-specific considerations required to support appropriate care.

This is where compliance, information technology, clinical operations, and leadership need to work together. AI governance cannot sit entirely within one department when the technology has the potential to affect patient care, reimbursement, data, or regulatory exposure.

Make Risk Assessments Part of an Ongoing Process

A strong compliance program depends on understanding current risks and responding when those risks change. The Medicare Advantage ICPG reinforces the importance of risk assessments and the need to connect identified risks with corrective actions and ongoing evaluation.

A useful risk assessment should help your organization:

• Identify current and emerging Medicare Advantage compliance risks

• Determine which departments and individuals own each risk

• Document the controls and corrective actions addressing those risks

• Evaluate whether those controls actually work

• Carry lessons from previous findings into future risk assessments

That last point matters because a risk assessment should continue to inform your compliance strategy after the document gets completed. If you identify a significant issue, implement a corrective action, and then never evaluate whether the corrective action worked, you have missed an important part of the compliance process.

Compliance Responsibility Cannot Simply Disappear

The guidance also raises important questions about how organizations structure their compliance functions. Smaller healthcare organizations may not have the resources to employ a full-time compliance officer, but that does not mean the organization needs to transfer its entire compliance responsibility to an outside party.

Healthcare organizations can use fractional compliance officers, consultants, advisors, mentors, external auditors, and compliance program effectiveness reviews to supplement their internal capabilities. There still needs to be someone within the organization who owns the compliance function, understands the organization’s risks, works with leadership, and can demonstrate how the organization responds to compliance concerns.

Consider How Financial Decisions Affect Compliance

The OIG also identifies vertically integrated and other ownership structures as an area of potential risk. The discussion in the guidance connects this concern to organizations where financial objectives could influence decisions involving patient care, utilization, marketing, reimbursement, or other healthcare operations.

This creates an important role for compliance professionals because financial and operational pressures exist in virtually every healthcare organization. A compliance professional may find themselves sitting across the table from financial leadership when a proposed decision creates potential overpayment, quality, regulatory, or patient-care concerns.

The goal is not to prevent organizations from making financially responsible decisions. The goal is to ensure that financial considerations receive appropriate scrutiny when they intersect with compliance obligations and the delivery of healthcare.

Use the Guidance to Strengthen Your Compliance Strategy

The OIG Guidance In Medicare Advantage gives healthcare organizations another resource for evaluating whether their compliance programs address the risks associated with Medicare Advantage operations. Although the guidance does not carry the force of a regulation, organizations should understand how the OIG uses guidance to communicate its expectations and how those expectations can become relevant during enforcement activity and Corporate Integrity Agreements.

The practical work begins with understanding which parts of the guidance apply to your organization. From there, look at your risk assessment, examine your existing controls, involve the operational leaders responsible for those processes, and determine whether your organization can demonstrate that it identifies risks, takes corrective action, and evaluates whether those actions actually work.

A defensible compliance program should be an active part of how your organization operates. The OIG Guidance In Medicare Advantage provides another opportunity to examine that program through the specific risks affecting Medicare Advantage today, including quality of care, utilization management, data integrity, artificial intelligence, marketing, financial incentives, and the relationships between organizations throughout the healthcare system.